tirzepatide for kidney disease GLP therapies have established themselves as kidney-protective in type 2 diabetes and high risk of disease. This new post-hoc analysis of SURPASS-CVOT's kidney outcomes shows greater kidney protection with (#mounjaro) A Study of Tirzepatide (LY3298176)
Description
Gudbergsen H, et al
Write the date on the pen so you do not forget
As of now, it is one of the most expensive diabetes and weight loss treatments
[CrossRef] [PubMed] [Google Scholar] Sex differences in response to treatment with glucagon-like peptide-1 receptor agonists: opportunities for a tailored approach to diabetes and obesity care
While more research is needed, early studies suggest that Semaglutide may help reduce inflammation in the gut, potentially offering relief to individuals with IBD
